EXPRESSION AND DISTRIBUTION OF ATRIAL-NATRIURETIC-PEPTIDE IN HUMAN HYPERTROPHIC VENTRICLE OF HYPERTENSIVE HEARTS AND HEARTS WITH HYPERTROPHIC CARDIOMYOPATHY

被引:67
|
作者
TAKEMURA, G
FUJIWARA, H
MUKOYAMA, M
SAITO, Y
NAKAO, K
KAWAMURA, A
ISHIDA, M
KIDA, M
UEGAITO, T
TANAKA, M
MATSUMORI, A
FUJIWARA, T
IMURA, H
KAWAI, C
机构
[1] KYOTO UNIV, FAC MED,DEPT INTERNAL MED,DIV 3,54 KAWARA CHO, SAKYO KU, KYOTO 606, JAPAN
[2] KYOTO UNIV, FAC MED, DEPT INTERNAL MED, DIV 2, KYOTO 606, JAPAN
[3] KYOTO WOMENS UNIV, KYOTO, JAPAN
关键词
VENTRICLE; HYPERTENSION; ATRIAL NATRIURETIC PEPTIDE; HYPERTROPHIC CARDIOMYOPATHY;
D O I
10.1161/01.CIR.83.1.181
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate the ventricular expression of atrial natriuretic peptide (ANP) in human hypertrophic hearts, we conducted an immunohistochemical study of 130 endomyocardial biopsy specimens obtained from the right side of the ventricular septum (RVB), left ventricular free wall (LVB), or both from a total of 80 patients: 44 patients with hypertrophic cardiomyopathy (HCM), 14 with apical hypertrophic cardiomyopathy (APH), 13 with hypertensive hearts (HHD), and nine without hypertrophy (controls). No patients had apparent congestive hearts (HHD), and nine without hypertrophy (controls). No patients had apparent congestive heart failure. ANP was not seen in ventricular myocytes in controls but was identified in biopsy specimens of hypertrophic hearts, and its distribution was characteristic in each hypertrophic group: 15 RBV (37%) and two LVB (7%) of the HCM group, one RBV (7%) and two LVB (18%) of the APH group, and zero RVB (0%) and five LVB (46%) of the HHD group. Clinical data (including echocardiographic, hemodynamic, and angiographic data) were not directly related to ventricular ANP expression in HCM, APH, or HHD with one exception. In HHD patients, LVB specimens with ANP showed greater ventricular wall thickness than LVB specimens without ANP. According to histological data, however, the ANP-present RVB specimens without ANP. According to histological data, however, the ANP-present RVB specimens of HCM or ANP-present LVB specimens of HHD had greater myocyte size than did the ANP-absent specimens. In addition, in HCM patients, the ANP-present RVB specimens showed more severe fibrosis and myofiber disarray than did the ANP-absent specimens. We conclude that a failing state and hemodynamic overload are not likely to be indispensable for ANP expression in human hypertrophic ventricles and that ventricular ANP expression occurs as a response to disease-specific changes: hemodynamic overload in HHD and histological changes such as myocardial fiber disarray, hypertrophy of myocytes, and fibrosis in HCM, which may reflect the characteristic distribution of intraventricular ANP.
引用
收藏
页码:181 / 190
页数:10
相关论文
共 50 条
  • [41] Growth Differentiation Factor-15 can Distinguish Between Hypertrophic Cardiomyopathy and Hypertensive Hearts
    Hanatani, Shinsuke
    Izumiya, Yasuhiro
    Takashio, Seiji
    Araki, Satoshi
    Rokutanda, Taku
    Yamamuro, Megumi
    Kojima, Sunao
    Ogawa, Hisao
    [J]. JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S188 - S188
  • [42] HYPERTROPHIC AND DEGENERATIVE CHANGES IN HUMAN HEARTS WITH AGING
    BAKER, PB
    ARN, AR
    UNVERFERTH, DV
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (02) : 536 - 536
  • [43] DEVELOPMENTAL PATTERN OF VENTRICULAR ATRIAL-NATRIURETIC-PEPTIDE (ANP) EXPRESSION IN CHRONICALLY HYPOXIC RATS AS AN INDICATOR OF THE HYPERTROPHIC PROCESS
    MCKENZIE, JC
    KELLEY, KB
    MERISKOLIVERSIDGE, EM
    KENNEDY, J
    KLEIN, RM
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1994, 26 (06) : 753 - 767
  • [44] QUANTITATIVE-ANALYSIS OF THE NARROWINGS OF INTRAMURAL SMALL ARTERIES IN NORMALS, HYPERTENSIVE HEARTS AND HYPERTROPHIC CARDIOMYOPATHY
    TANAKA, M
    ONODERA, T
    WU, DJ
    MATSUDA, M
    TAKEMURA, G
    ISHIDA, M
    KAWAMURA, A
    FUJIWARA, H
    KAWAI, C
    [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1987, 51 (08): : 896 - 896
  • [45] ATRIAL-NATRIURETIC-PEPTIDE IN CHRONICALLY HYPERTENSIVE DOGS
    SEYMOUR, AA
    ASAAD, MM
    SHELDON, JH
    SMITH, PL
    ROGERS, WL
    [J]. HYPERTENSION, 1995, 26 (04) : 634 - 641
  • [46] TISSUE DISTRIBUTION OF ATRIAL-NATRIURETIC-PEPTIDE
    MALLON, E
    MCINTYRE, GM
    LINDOP, GBM
    [J]. JOURNAL OF PATHOLOGY, 1986, 148 (01): : A68 - A69
  • [47] EXPRESSION OF ATRIAL NATRIURETIC POLYPEPTIDE IN ENDOMYOCARDIAL BIOPSY SPECIMENS OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    TAKEMURA, G
    FUJIWARA, H
    UEGAITO, T
    KIDA, M
    MATSUMORI, A
    FUJIWARA, T
    KAWAI, C
    [J]. CIRCULATION, 1990, 82 (04) : 399 - 399
  • [48] VASOPRESSIN-MEDIATED ATRIAL-NATRIURETIC-PEPTIDE RELEASE FROM ISOLATED WORKING RAT HEARTS
    BOYLE, WA
    LEE, JS
    SEGEL, LD
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 (06) : 1325 - 1325
  • [49] Plasma brain natriuretic peptide and mortality in hypertrophic cardiomyopathy
    Kitaoka, H
    Okawa, M
    Kubo, T
    Yamasaki, N
    Matsumura, Y
    Furuno, T
    Doi, Y
    [J]. CIRCULATION, 2003, 108 (17) : 448 - 448
  • [50] Brain natriuretic peptide level in patients with hypertrophic cardiomyopathy
    Demkina, A. E.
    Krylova, N. S.
    Poteshkina, N. G.
    Kovalevskaya, E. A.
    Hashieva, F. M.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 565 - 565